Thomas Kosten
Director · Baylor College of Medicine
Credentials: · · ·
History
- Present
- 1983–1984
Addiction Psychiatry
- 1979–1983
Psychiatry
Research
Substance use disorders in patients with posttraumatic stress disorder: a review of the literature
Review · American Journal of Psychiatry · 2001 · Last of 3 authors · 654 citations
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Review · Neuropsychopharmacology · 1998 · 622 citations
Systematic review or meta-analysis · Annals of Internal Medicine · 2007 · 572 citations
- BR
56 papers
56 papers
- FO
25 papers
- MS
25 papers
- PJ
23 papers
21 papers · 8 as a fellow
- SW
19 papers
- KG
18 papers
Grants
- 2017–2018
Methamphetamine Vaccine for Humans
National Institute on Drug Abuse · R42
PI · $306K · Kadvax Technologies, Inc.
- 2015–2018
Complementary Combination Therapy for Cocaine Dependence
National Institute on Drug Abuse · R01
Contact PI · $387.2K · Baylor College of Medicine
- 2011–2017
Human Methamphetamine Vaccine: Translational Avante Garde Award
National Institute on Drug Abuse · DP1
Contact PI · $4M · Baylor College of Medicine
- 2004–2015
Stimulant Pharmacotherapy: Noradrenergic Targets
National Institute on Drug Abuse · P50
Contact PI · $12.6M · Baylor College of Medicine
Clinical trials
- 2021–2026
Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
Principal investigator · Completed · Phase 2
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
- 2017–2019
Entolimod, an Adjuvant for Vaccine Augmentation
Principal investigator · Completed · Early phase 1
Baylor College of Medicine
- 2013–2016
A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
Principal investigator · Terminated · Phase 2
Baylor College of Medicine
- 2010–2014
Multisite Controlled Trial of Cocaine Vaccine
Principal investigator · Completed · Phase 2
Baylor College of Medicine